Author: Armin Ensser; Klaus Ueberla
Title: Determination of daily reproduction numbers of SARS-CoV2 based on death cases suggests more rapid initial spread in Italy and the United States Document date: 2020_3_31
ID: 4izymiy4_1
Snippet: Integration, an obligate step in retrovirus replication, is defined as the covalent insertion of viral DNA into the host cell genome. Human immunodeficiency virus type 1 (HIV-1) proviruses appear to contribute to viral persistence. This is most evident in treated patients, where the proviral load seems to be unaffected by combination antiretroviral therapy that clears viremia (10) . To date, proviral DNA has proven impossible to eradicate without.....
Document: Integration, an obligate step in retrovirus replication, is defined as the covalent insertion of viral DNA into the host cell genome. Human immunodeficiency virus type 1 (HIV-1) proviruses appear to contribute to viral persistence. This is most evident in treated patients, where the proviral load seems to be unaffected by combination antiretroviral therapy that clears viremia (10) . To date, proviral DNA has proven impossible to eradicate without death of the transduced host cell. These results suggest that provirus may serve as a treatment-resistant reservoir of HIV-1. Quantitative studies of this reservoir are challenging because of the relative rarity of integration events in quiescent leukocytes. Assays for HIV-1 integration have been implemented using three main strategies, namely, inverse PCR (7), linker-primer PCR (37) , and Alu PCR (2, 3, 5, 12, 34) . We focus on and refine the latter method here.
Search related documents:
Co phrase search for related documents- antiretroviral therapy and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antiretroviral therapy and integration assay: 1
- antiretroviral therapy and main strategy: 1
- antiretroviral therapy and proviral dna: 1, 2
- antiretroviral therapy and quantitative study: 1, 2, 3
- antiretroviral therapy and viral dna: 1, 2, 3, 4
- antiretroviral therapy and viral persistence: 1, 2, 3
- antiretroviral therapy and virus type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- host cell and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- host cell and obligate step: 1, 2
- host cell and proviral dna: 1, 2
- host cell and quantitative study: 1, 2, 3, 4, 5, 6, 7
- host cell and viral dna: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
- host cell and viral persistence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- host cell and viral persistence contribute: 1
- host cell and virus type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- host cell genome and human immunodeficiency: 1, 2, 3, 4
- host cell genome and proviral dna: 1
- host cell genome and viral dna: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date